Cancer Biomarkers

A cancer biomarker refers to a substance or technique this is indicative of the presence of cancer inside the frame. A biomarker may be a molecule secreted via a tumour or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycolic, and imaging biomarkers can be used for cancer prognosis, diagnosis, and epidemiology. Whilst a few most cancers biomarkers can be used to be expecting how aggressively your cancer will develop, and are consequently beneficial for assessing your analysis, the maximum promising use of biomarkers these days is to pick out which cures a patient’s cancer may additionally or might not respond to.

  • Diagnostic Biomarkers
  • Predictive & Prognostic Biomarkers
  • Tumour Suppressors Biomarkers
  • Molecular Cancer Biomarkers

Related Conference of Cancer Biomarkers

July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in